For example, in some studies, CD68+ Mφs were correlated negatively with patient prognosis [32]; whereas, we and other groups have shown that GC patients with a high tumor-associated macrophage (TAM) count had better outcomes than those with a low TAM count [17, 33]. The gene discussed is CD68; the disease is gastric cancer.